McIvor, Andrew
Kaplan, Alan
Article History
Received: 16 March 2020
Accepted: 15 October 2020
First Online: 4 December 2020
Competing interests
: A.M. has received honoraria for attending advisory boards, providing continuing medical education and participating in clinical trials as an investigator from AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Pfizer, Merck and Novartis. A.K. received non-financial support from AstraZeneca during the conduct of the study; personal fees from AstraZeneca, Covis, GlaxoSmithKline, Novo Nordisk, Novartis, Pfizer, Purdue, Sanofi and Teva; and personal fees and non-financial support from Boehringer Ingelheim, Pfizer, Novartis and Trudell, outside the submitted work. The meetings and outputs of the Steering Group are funded by AstraZeneca, as part of activities seeking to encourage solutions to improve asthma management across all stakeholders. MHP Communications, whose services are also paid for by AstraZeneca, supports with the administration and running of the Steering Group. Participation in the Steering Group was not financially supported by AstraZeneca.